Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 154B 133B 122B 115B 216B 14,548B 218B 1,449B 564B 7,140B 579B 566B 24,700B P/E 2026 *
22.3x
P/E 2027 * 19.1x
Enterprise Value 166B 143B 132B 124B 233B 15,654B 235B 1,559B 607B 7,683B 623B 609B 26,579B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.98x
Free-Float
86.73%
Yield 2026 *
2.88%
Yield 2027 * 3.07%
1 day+0.36%
1 week-0.31%
Current month+6.10%
1 month+7.15%
3 months-19.37%
6 months-27.85%
Current year-26.50%
1 week 75.92
Extreme 75.92
78.1
1 month 73.4
Extreme 73.4
79.48
Current year 70.1
Extreme 70.1
109.64
1 year 70.1
Extreme 70.1
119.28
3 years 70.1
Extreme 70.1
134.2
5 years 70.1
Extreme 70.1
134.2
10 years 49.6
Extreme 49.6
134.2
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-0.31% - - 158B
-3.91%-2.63%-9.32%-12.35% 104B
+1.29%+8.91%+62.93%+60.04% 56.43B
-1.55%-1.48%-5.49%+51.41% 54.76B
-2.45%-4.18%-16.67%-45.25% 40B
-1.81%-0.33% - - 31.36B
-2.64%-4.73%-12.95%-45.25% 28.23B
-1.82%-2.22%+48.39%-10.62% 23.28B
+0.45%-0.44%-14.31%-4.17% 20.41B
-3.44%-4.18%-15.89%-6.65% 20.13B
Average -1.58%-1.55%+4.59%-1.60% 42.11B
Weighted average by Cap. -1.31%-1.06%+5.06%+3.91%

Financials

2026 *2027 *
Net sales 50.29B 43.38B 39.89B 37.54B 70.55B 4,746B 71.14B 473B 184B 2,329B 189B 185B 8,058B 54.79B 47.27B 43.46B 40.91B 76.86B 5,171B 77.51B 515B 201B 2,538B 206B 201B 8,780B
Net income 7.02B 6.06B 5.57B 5.24B 9.85B 662B 9.93B 65.97B 25.68B 325B 26.34B 25.78B 1,125B 8.39B 7.24B 6.66B 6.27B 11.77B 792B 11.87B 78.88B 30.71B 389B 31.5B 30.82B 1,345B
Net Debt 11.73B 10.12B 9.3B 8.75B 16.45B 1,107B 16.59B 110B 42.91B 543B 44.01B 43.07B 1,879B 8.88B 7.66B 7.05B 6.63B 12.46B 838B 12.57B 83.49B 32.51B 411B 33.34B 32.63B 1,423B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
17/06/26 77.88 +0.36%
16/06/26 77.60 +1.94%
15/06/26 76.12 +0.26%
12/06/26 75.92 -2.11%
11/06/26 77.56 -0.72%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
88.50USD
Average target price
116.54USD
Spread / Average Target
+31.69%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!